Our ongoing programs and collaborative efforts on heart health, in partnerhip with Pfizer, are making a significant impact in raising awareness about the prevalence of cardiovascular disease within the Hispanic community. It underscores the importance of prioritizing policy and programs aimed at educating and treating high-risk patients with Atrial Fibrillation.
|